These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36226843)

  • 1. Patient-reported outcome measures in birch pollen allergic patients treated with sublingual immunotherapy reflect real life.
    Bahbah F; Gentil C; Sousa-Pinto B; Canonica GW; Devillier P; Pfaar O; Bousquet J
    Allergy; 2023 Apr; 78(4):1113-1116. PubMed ID: 36226843
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study.
    Pfaar O; van Twuijver E; Boot JD; Opstelten DJ; Klimek L; van Ree R; Diamant Z; Kuna P; Panzner P
    Allergy; 2016 Jan; 71(1):99-107. PubMed ID: 26417901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual allergen immunotherapy with a liquid birch pollen product in patients with seasonal allergic rhinoconjunctivitis with or without asthma.
    Pfaar O; Bachert C; Kuna P; Panzner P; Džupinová M; Klimek L; van Nimwegen MJ; Boot JD; Yu D; Opstelten DJE; de Kam PJ
    J Allergy Clin Immunol; 2019 Mar; 143(3):970-977. PubMed ID: 30508538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of oral immune cells in birch pollen-allergic patients: impact of the oral allergy syndrome and sublingual allergen immunotherapy on antigen-presenting cells.
    Mascarell L; Rak S; Worm M; Melac M; Soulie S; Lescaille G; Lemoine F; Jospin F; Paul S; Caplier L; Hasséus B; Björhn C; Zeldin RK; Baron-Bodo V; Moingeon P
    Allergy; 2015 Apr; 70(4):408-19. PubMed ID: 25631199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose escalation using carbamylated monomeric tree pollen drops is well tolerated in patients with allergic rhinoconjunctivitis and points towards clinical effects.
    Raskopf E; Allekotte S; Compalati E; Singh J; Acikel CH; Mösges R
    Allergy; 2019 Nov; 74(11):2273-2276. PubMed ID: 31106436
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunologic response and safety in birch pollen sublingual versus oral vestibule immunotherapy: a pilot study.
    Allam JP; Wuestenberg E; Wolf H; Klimek L; Decot E; Horn A; Schnitker J; Bieber T; Novak N
    J Allergy Clin Immunol; 2014 Jun; 133(6):1757-9.e3. PubMed ID: 24794686
    [No Abstract]   [Full Text] [Related]  

  • 7. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit.
    Ellis AK; Tenn MW; Steacy LM; Adams DE; Day AG; Walker TJ; Nolte H
    Ann Allergy Asthma Immunol; 2018 May; 120(5):495-503.e2. PubMed ID: 29432967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oralair Birch, a recombinant major birch pollen allergen tablet for sublingual immunotherapy of allergic rhinitis caused by birch pollen.
    Larenas-Linnemann D
    Curr Opin Investig Drugs; 2010 May; 11(5):586-96. PubMed ID: 20419605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conjunctival provocation tests: a predictive factor for patients' seasonal allergic rhinoconjunctivitis symptoms.
    Kruse K; Gerwin E; Eichel A; Shah-Hosseini K; Mösges R
    J Allergy Clin Immunol Pract; 2015; 3(3):381-6. PubMed ID: 25609338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen immunotherapy for allergic rhinitis due to birch pollen? A tasty proposal!
    Bergmann KC
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):1130. PubMed ID: 32557947
    [No Abstract]   [Full Text] [Related]  

  • 11. Allergen immunotherapy for birch-apple syndrome: what do we know?
    Incorvaia C; Ridolo E; Mauro M; Russello M; Pastorello E
    Immunotherapy; 2017 Nov; 9(15):1271-1278. PubMed ID: 29130794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate and lymphocytic response of birch-allergic patients before and after sublingual immunotherapy.
    Guida G; Boita M; Scirelli T; Bommarito L; Heffler E; Badiu I; Bellone G; Mietta S; Mistrello G; Rolla G
    Allergy Asthma Proc; 2012; 33(5):411-5. PubMed ID: 22762741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study.
    Cirla AM; Cirla PE; Parmiani S; Pecora S
    Allergol Immunopathol (Madr); 2003; 31(1):31-43. PubMed ID: 12573207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients.
    Pfaar O; Biedermann T; Klimek L; Sager A; Robinson DS
    Allergy; 2013 Oct; 68(10):1306-13. PubMed ID: 23991896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 2 Years of Treatment With Sublingual Grass Pollen Immunotherapy on Nasal Response to Allergen Challenge at 3 Years Among Patients With Moderate to Severe Seasonal Allergic Rhinitis: The GRASS Randomized Clinical Trial.
    Scadding GW; Calderon MA; Shamji MH; Eifan AO; Penagos M; Dumitru F; Sever ML; Bahnson HT; Lawson K; Harris KM; Plough AG; Panza JL; Qin T; Lim N; Tchao NK; Togias A; Durham SR;
    JAMA; 2017 Feb; 317(6):615-625. PubMed ID: 28196255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical efficacy of sublingual and subcutaneous birch pollen allergen-specific immunotherapy: a randomized, placebo-controlled, double-blind, double-dummy study.
    Khinchi MS; Poulsen LK; Carat F; André C; Hansen AB; Malling HJ
    Allergy; 2004 Jan; 59(1):45-53. PubMed ID: 14674933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic reactions to immunotherapy during mountain cedar season: implications for seasonal dose adjustment.
    Wong PH; Quinn JM; Gomez RA; Webb CN
    J Allergy Clin Immunol Pract; 2017; 5(5):1438-1439.e1. PubMed ID: 28499782
    [No Abstract]   [Full Text] [Related]  

  • 18. [For the family physician allergy season is all year long. Strategies against running noses].
    Wiedemann B
    MMW Fortschr Med; 2002 Nov; 144(45):4-6. PubMed ID: 12534052
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy with sublingual birch pollen extract. A short-term double-blind placebo study.
    Horak F; Stübner P; Berger UE; Marks B; Toth J; Jäger S
    J Investig Allergol Clin Immunol; 1998; 8(3):165-71. PubMed ID: 9684190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.